Drug Discovery

This group focuses on the development of next generation drugs and molecules with potential biological applications. The group is especially interested in exploring the chemical space for cancer treatment, in the molecules that can modulate the activity of viruses of the Flaviviridae family, especially HCV and the dengue fever virus and in molecules that can help in the understanding of the mechanism of action of potential inhibitor. Currently, this group is working on the check-point kinase 2 inhibitors, p53 peptidomimetics (both of which are potentially useful targets for therapeutic intervention in cancer treatment) and anti-malarial drugs.